Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20211104052964N1Phase 3Completed
Phase 3, randomised, open-label trial of chlorhexidine in None (2 arms), sponsored by Qazvin University of Medical Sciences. Primary endpoint: Salivary pH. Started May 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20211104052964N1.